Cover Image

Randomized, open-label, phase II study comparing the efficacy and the safety of cabazitaxel versus weekly paclitaxel given as neoadjuvant treatment in patients with operable triple negative or luminal B/HER2 normal breast cancer (GENEVIEVE)

Saved in:
Bibliographic Details
Main Authors: Paepke, Stefan (Author) , Huober, Jens (Author) , Kümmel, Sherko (Author) , Eidtmann, Holger (Author) , Untch, Michael (Author) , Costa, Serban Dan (Author) , Blohmer, Jens-Uwe (Author) , Eiermann, Wolfgang (Author) , Gerber, Bernd (Author) , Hanusch, Claus Alexander (Author) , Hilfrich, Jörn (Author) , Jackisch, Christian (Author) , Schneeweiss, Andreas (Author) , Denkert, Carsten (Author) , Engels, Knut (Author) , Klare, Peter (Author) , Fasching, Peter Andreas (Author) , Burchardi, Nicole Diana (Author) , Loibl, Sibylle (Author) , Minckwitz, Gunter von (Author)
Format: Article (Journal)
Language:English
Published: 2016
In: The European journal of cancer
Year: 2016, Volume: 57, Pages: 98-99
ISSN:0959-8049
Online Access: Get full text
Author Notes:S. Paepke, J. Huober [and 16 others]
Description
ISSN:0959-8049

Similar Items